T4N5 liposomal lotion in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant

Journal of Drugs in Dermatology, Oct, 2007

Sponsors and Collaborators: Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham and National Cancer Institute (NCI). This randomized phase II trial is studying how well T4N5 liposomal lotion works in preventing the recurrence of nonmelanoma skin cancer in patients who have undergone a kidney transplant.

Condition                    Intervention                  Phase

Nonmelanomatous Skin Cancer  Drug: T4N5 liposomal lotion   Phase II
Precancerous/Nonmalignant    Procedure: cancer prevention
  Condition                    intervention
                             Procedure: chemoprevention
                               of cancer

Study ID Numbers: CDR0000378098; UAB-0323

ClinicalTrials.gov Identifier: NCT00089180